Dwight-Englewood Earns Designation as One of New Jersey’s Top Schools

Cambridge Therapeutics leader John Klein has been in the pharmaceutical industry for nearly 30 years. In addition to his professional commitments to healthcare, John Klein is interested in improving education in his home state of New Jersey, where he serves as a trustee of the private preparatory school Dwight-Englewood, also known as D-E.

The Dwight-Englewood School teaches children from kindergarten through high school in an innovative setting that emphasizes academic excellence. Recently, the community website Niche.com ranked D-E third among the top 100 private and public schools at all grade levels in the state and second among state private schools only. It earned a grade rating of A+.

Factors considered for the evaluation of New Jersey’s schools included not only academics, but also the racial and economic diversity of the student population, parent and student experiences, and teacher performance, along with a collection of smaller factors. Dwight-Englewood’s ranking in this list is made even more impressive by the fact that US News and World Report ranks New Jersey as the second-best state in the country for education, behind only Massachusetts.

Comments

Bilogix Implements Enterprise Performance Management Solutions

The chairman of Alpine, New Jersey-based Cambridge Therapeutics, John Klein offers next-generation solutions in areas ranging from combination therapies to drug delivery. Building on his experience with Cambridge Therapeutics, John Klein recently launched Bilogix in Alpine, NJ, a provider of enterprise performance management (EPM) consulting services. Encompassing processes and applications, the EPM approach is one that transforms key performance indicator (KPI) data into highly accurate ways of analyzing, monitoring, measuring, and forecasting organizational results. It adds value through bringing focus on the details of how strategic plans are envisioned and implemented, as well as how challenges and inconsistencies are addressed when they occur. This ensures that resources are utilized more efficiently toward defined goals, at both the operational and tactical levels. At the same time, the effects of business intelligence investments can be tracked via a dashboard and r...

Costs Associated with Enterprise Performance Management

An award-winning pharmaceutical executive based in Alpine, New Jersey, John Klein founded Cambridge Therapeutics and Bi-Logix, LLC, in 2011 and 2015, respectively (both located in Alpine, NJ). Bi-Logix, LLC, is an enterprise performance management (EPM) firm that helps companies obtain sustainable measured performance via its proprietary business solutions and methodology, which is copyrighted by John Klein. EPM solutions help businesses improve their IT infrastructure and increase overall corporate efficiency, which, in turn, helps them cut costs and increase revenue. While there are costs associated with EPM implementation, its long-term benefits significantly outweigh the impact of short-term spending. In addition to paying for EPM software licensing and maintenance, businesses might also have to budget costs for database software to help run the EPM. Other costs that might be accrued include the maintenance and upgrading of hardware, as well as fees for third-party inte...

NJ Attorney General Reveals Measures to Combat Opioid Epidemic

The chairman of Cambridge Therapeutics in Teaneck, New Jersey, John Klein has obtained FDA approval for more than 300 generic drugs in the course of his 30-year career. His work at Cambridge Therapeutics has resulted in honors including high ranking on Forbes’ list of the Top 100 CEOs. Complementing that work, John Klein closely follows health and related developments in New Jersey. The state’s attorney general, Gurbir Grewal, recently announced new efforts aimed at battling the state’s opioid epidemic. Grewal has proposed a rule change to make medication-assisted treatment, long recognized as the most effective way to treat opioid addiction, more widely available to the state’s residents through use of telemedicine technology. Allowing physicians to assess and prescribe treatments to patients through two-way, real-time video communication will ensure more people can access medication-assisted treatment and improve their odds of surviving their opioid addiction. In addition, Grewa...

John Klein - Guiding Cambridge Therapeutics in New Jersey

Search This Blog